Evidence map›Paper›PMID 42665337›Full record

ReviewBMJ open2026

Partnering with patients and the public in the clinical trials ecosystem: a decade of lessons learned and shared.

Dawn P Richards, Christopher Fink, Marisa Granieri, Kathy Kobow, Therese Lane, Donna Lillie, Kimberly Mitchell, Charlotte Munro, Maureen Smith, Murray Walz and 1 more

Abstract readReview
In one paragraph

Review in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dawn P RichardsClinical Trials Ontario, Toronto, Ontario, Canada dawn.richards@ctontario.ca.ORCID 0000-0003-1151-0826
Christopher FinkPatient Author, Toronto, Ontario, Canada.
Marisa GranieriCollege of Lived Experience, Clinical Trials Ontario, Toronto, Ontario, Canada.
Kathy KobowCollege of Lived Experience, Clinical Trials Ontario, Toronto, Ontario, Canada.
Therese LanePatient Author, Toronto, Ontario, Canada.
Donna LilliePatient Author, Toronto, Ontario, Canada.
Kimberly MitchellPatient Author, Toronto, Ontario, Canada.
Charlotte MunroCollege of Lived Experience, Clinical Trials Ontario, Toronto, Ontario, Canada.
Maureen SmithCollege of Lived Experience, Clinical Trials Ontario, Toronto, Ontario, Canada.
Murray WalzCollege of Lived Experience, Clinical Trials Ontario, Toronto, Ontario, Canada.
Susan MarlinClinical Trials Ontario, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the health research space, it is becoming more common to see patient and public partners as members of teams and contributing to various initiatives rather than solely as participants in research. We use the term patient and public engagement (PPE) to describe this approach. While reporting mechanisms such as the Guidance for Reporting Involvement of Patients and the Public, Version 2 (GRIPP2), are being used to share teams' PPE efforts related to specific research projects, to date we have seen less about how organisations have collaborated with patient and public partners on a broader scale. Clinical Trials Ontario (CTO) is a not-for-profit organisation in the clinical trials space that has been set up to improve the environment for trials rather than conduct trials. We share CTO's PPE processes, how they have evolved over the past decade, outputs related to this work, and lessons learned.

methodsPatient and public partners and team members from CTO used a co-production model. We have co-developed PPE processes to guide and carry out the work under CTO's strategic pillar of Engage. The Patient and Public Engagement Evaluation Tool has played a role in helping ensure CTO's approaches to co-production are on track. Feedback and insights provided in the evaluation tool after engagements have resulted in iterative changes to this work.

resultsCTO has engaged patient and public partners in its work since its inception in 2014. Gradually, this work has evolved based on both the needs of CTO and the patient and public partners with whom it collaborates. Originally, a small group called the patient and public advisory group was created, which met quarterly in person and provided guidance related to specific products (eg, CTO's website about clinical trials, a clinical trial finder). Based on lessons learned with that group and the abilities of people to participate, the group was expanded to become CTO's College of Lived Experience. The College of Lived Experience includes more perspectives and meets more frequently and predominantly virtually, having been formed just before the COVID-19 pandemic was declared. Working with the College has resulted in: members being embedded in a range of CTO projects, a number of public-facing outputs and generating a research idea and carrying out a project that resulted in a patient partner co-authored, peer-reviewed publication. The College is also available to and has provided input and insights into projects and initiatives outside of CTO. We share lessons learned from organisational perspectives and from those College members who are co-authors of this work.

conclusionsCTO's work in PPE has resulted in a co-production model that is critical to efforts in CTO's Engage strategic pillar and beyond. We provide templates and outputs of this co-production work and lessons learned. We hope our work helps other clinical trials organisations across the globe to include patient and public partners in their operational efforts.

Indexed as

Clinical Trials as TopicCommunity ParticipationPatient ParticipationCOVID-19HumansOntarioClinical TrialCommunity-Based Participatory ResearchPatients

Identifiers

PMID42665337
PMCPMC13536137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.